WQ
GSK icon

Wealth Quarterback’s GSK GSK Stock Holding History

Wealth Quarterback’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$219K Sell
4,171
-308
-7% -$16.3K 0.07% 162
2026
Q1 		$247K Buy
4,479
+33
+0.7% +$1.79K 0.1% 144
2025
Q4 		$218K Buy
+4,446
New +$207K 0.08% 144
2021
Q3 		$23K Buy
1,986
+1,322
+199% +$66.4K 0.02% 343
2021
Q2 		$34K Buy
+664
New +$31.9K 0.02% 282
2020
Q2 		– Sell
-1,627
Closed -$74.7K – 368
2020
Q1 		$74.7K Sell
1,627
-432
-21% -$23K 0.07% 176
2019
Q4 		$121K Buy
+2,059
New +$115K 0.11% 144

Other funds holding GSK

DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
TH
Transmarket Holdings Chicago, Illinois $136M AUM
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return

Wealth Quarterback's GSK Position: Q2 2026 in Review

Wealth Quarterback reduced its GSK (GSK) stake by 6.9% in Q2 2026, selling an estimated $16.3K and leaving 4,171 shares worth $219K. The position accounts for 0.07% of the portfolio, ranked #162.

Wealth Quarterback first reported a position in GSK in Q4 2019 and has held it in 7 quarters since. The position peaked at $247K in Q1 2026. 304 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Wealth Quarterback held 4,171 shares of GSK worth $219K as of Q2 2026.
  • Wealth Quarterback sold 308 GSK shares in Q2 2026, an estimated $16.3K.
  • GSK made up 0.07% of Wealth Quarterback's portfolio in Q2 2026, its #162 holding.
  • Wealth Quarterback first reported a position in GSK in Q4 2019 and has held it in 7 quarters since.
  • Wealth Quarterback's GSK position peaked at $247K in Q1 2026.
  • 304 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Wealth Quarterback's 13F filing for Q2 2026, filed 27 Jul 2026.